Last SFr.79.60 CHF
Change Today -0.05 / -0.06%
Volume 2.4M
NOVN On Other Exchanges
Symbol
Exchange
SIX Swiss Ex
Xetra
New York
OTC US
Mexico
Frankfurt
SIX Swiss Ex
As of 11:43 AM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Hans-Ulrich Doerig Ph.D.

Former Director, Novartis AG
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 8 different industries.

74--

Background*

Dr. Hans-Ulrich Doerig, Ph.D. served as the President of Executive Board of Credit Suisse Group AG since 1996 and also served as its Chief Risk Officer from 1998 to 2002 and Vice Chairman of the Group Executive Board from 1998 to 2003. Dr. Doerig served as Chief Executive Officer of Credit Suisse First Boston since 1997. He served as a Member of the Executive Board of Credit Suisse since 1982 and was responsible for the multinational division, securities trading, capital ...

Read Full Background

Corporate Headquarters*

Lichtstrasse 35
Basel, Basel-Stadt 4056

Switzerland

Phone: 41 61 324 11 11
Fax: --

Board Members Memberships*

Former Chairman of The Board
Former Director
Former Director
2003-N/A
Former Director
2003-N/A
Former Vice Chairman, Chairman of Risk Committee and Member of Chairman’s and Governance Committee
2003-N/A
Former Vice Chairman, Chairman of Risk Committee and Member of Chairmans & Governance Committee
2003-N/A
Former Chairman and Chairman of Chairman's & Governance Committee
2004-N/A
Former Director

Education*

Unknown/Other Education
Universität St. Gallen
Doctorate 1968
Universität St. Gallen

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NOVN:VX SFr.79.60 CHF -0.05

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Paul Bulcke Chief Executive Officer, Member of Executive Board, Director and Member of Chairman's & Corporate Governance Committee
Nestlé S.A.
SFr.5.5M
Alan George Lafley Chairman of the Board, Chief Executive Officer, President and Member of Proxy Committee
The Procter & Gamble Company
$1.8M
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
Kenneth C. Frazier Chairman and Chief Executive Officer
Merck & Co. Inc.
$1.5M
Severin Schwan Ph.D.Chief Executive Officer and Director
Roche Holding AG
SFr.5.1M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVARTIS AG-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.